A

AVIR

Atea Pharmaceuticals, Inc.

2.95

0.000.00%
After Hours: 2.950  0.00  0.00%16:22 04/30 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

464.67M

594.97M

666.71M

772.89M

863.63M

Total Current Assets

462.36M

590.46M

660.92M

772.40M

863.48M

Total Non Current Assets

2.31M

4.51M

5.79M

489.00K

155.00K

Total Liabilities

25.80M

39.78M

26.14M

62.81M

315.83M

Total Current Liabilities

18.60M

32.38M

18.48M

56.88M

315.80M

Total Non Current Liabilities

7.20M

7.40M

7.66M

5.93M

36.00K

Total Equity

438.87M

555.19M

640.57M

710.08M

547.80M

Total Stockholders Equity

438.87M

555.19M

640.57M

710.08M

547.80M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

464.67M

594.97M

666.71M

772.89M

863.63M

Total Common Shares Outstanding

84.46M

83.44M

83.29M

83.10M

82.44M

Total Preferred Shares Outstanding

--

--

--

--

--